Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics

Xiaoshuai Ren,1,* Feng Lin,2,* Chaogang Tang,2,* Yao Liu,3 Guolei Liao,2 Jiabi Liang,3 Wenji Luo,3 Lei Zhang,2 Wenli Chen3 1Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China; 2Depa...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Ren X, Lin F, Tang C, Liu Y, Liao G, Liang J, Luo W, Zhang L, Chen W
פורמט: Article
שפה:English
יצא לאור: Dove Medical Press 2023-12-01
סדרה:Drug Design, Development and Therapy
נושאים:
גישה מקוונת:https://www.dovepress.com/identification-of-cholest-4-ene-36-dione-as-a-novel-neuroprotectant-in-peer-reviewed-fulltext-article-DDDT
_version_ 1827586359132422144
author Ren X
Lin F
Tang C
Liu Y
Liao G
Liang J
Luo W
Zhang L
Chen W
author_facet Ren X
Lin F
Tang C
Liu Y
Liao G
Liang J
Luo W
Zhang L
Chen W
author_sort Ren X
collection DOAJ
description Xiaoshuai Ren,1,* Feng Lin,2,* Chaogang Tang,2,* Yao Liu,3 Guolei Liao,2 Jiabi Liang,3 Wenji Luo,3 Lei Zhang,2 Wenli Chen3 1Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China; 2Department of Cerebrovascular Disease, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China; 3Department of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wenli Chen; Lei Zhang, Tel +15626471884 ; +13726209240, Email chenwenl@mail3.sysu.edu.cn; zhangl92@mail.sysu.edu.cnPurpose: Stroke is a leading cause of disability and death globally. However, there are few clinical drugs for stroke therapy. Novel and effective neuroprotectants are called on the way.Methods: In this study, 93 steroids from a constructed steroidal library were randomly numbered and blindly evaluated in an L-glutamate-induced HT-22 oxidative stress model. The neuroprotective effects of 5 candidates were further investigated in potassium deprivation-induced apoptosis of cerebellar granule neurons (CGNs), D-glutamate-induced excitotoxicity of CGNs, and cortical neuron (CN) models.Results: Interestingly, unblinding revealed that cholest-4-ene-3,6-dione (78), a cholesterol derivative, was first found to have comprehensive neuroprotective effects in all cell models. 78 administration also decreased the infarction volume and improved motor function in middle cerebral artery occlusion (MCAO) model rats. Additionally, 78 treatment decreased intercellular reactive oxygen species (ROS) and NO production in the HT-22 cell model. Finally, lipidomics and molecular docking results showed that 78 may exert its neuroprotective effects by increasing platelet-activating factor (PAF) analog 1-(9Z-pentadecenoyl)-glycero-3-phosphocholine production.Conclusion: This study indicates that 78, a novel neuroprotectant, is a promising therapeutic candidate with comprehensive neuroprotective effects for the treatment of ischemic stroke by decreasing ROS/reactive nitrogen species (RNS) levels and increasing 1-(9Z-pentadecenoyl)-glycero-3-phospho-choline production. Keywords: neuroprotection, cholest-4-ene-3,6-dione, anti-ROS, lipidomics, molecular docking
first_indexed 2024-03-09T00:01:00Z
format Article
id doaj.art-86dd7cb40d2547db86bded4d26de4e72
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-03-09T00:01:00Z
publishDate 2023-12-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-86dd7cb40d2547db86bded4d26de4e722023-12-12T18:00:05ZengDove Medical PressDrug Design, Development and Therapy1177-88812023-12-01Volume 173709372288930Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its LipidomicsRen XLin FTang CLiu YLiao GLiang JLuo WZhang LChen WXiaoshuai Ren,1,* Feng Lin,2,* Chaogang Tang,2,* Yao Liu,3 Guolei Liao,2 Jiabi Liang,3 Wenji Luo,3 Lei Zhang,2 Wenli Chen3 1Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China; 2Department of Cerebrovascular Disease, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China; 3Department of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wenli Chen; Lei Zhang, Tel +15626471884 ; +13726209240, Email chenwenl@mail3.sysu.edu.cn; zhangl92@mail.sysu.edu.cnPurpose: Stroke is a leading cause of disability and death globally. However, there are few clinical drugs for stroke therapy. Novel and effective neuroprotectants are called on the way.Methods: In this study, 93 steroids from a constructed steroidal library were randomly numbered and blindly evaluated in an L-glutamate-induced HT-22 oxidative stress model. The neuroprotective effects of 5 candidates were further investigated in potassium deprivation-induced apoptosis of cerebellar granule neurons (CGNs), D-glutamate-induced excitotoxicity of CGNs, and cortical neuron (CN) models.Results: Interestingly, unblinding revealed that cholest-4-ene-3,6-dione (78), a cholesterol derivative, was first found to have comprehensive neuroprotective effects in all cell models. 78 administration also decreased the infarction volume and improved motor function in middle cerebral artery occlusion (MCAO) model rats. Additionally, 78 treatment decreased intercellular reactive oxygen species (ROS) and NO production in the HT-22 cell model. Finally, lipidomics and molecular docking results showed that 78 may exert its neuroprotective effects by increasing platelet-activating factor (PAF) analog 1-(9Z-pentadecenoyl)-glycero-3-phosphocholine production.Conclusion: This study indicates that 78, a novel neuroprotectant, is a promising therapeutic candidate with comprehensive neuroprotective effects for the treatment of ischemic stroke by decreasing ROS/reactive nitrogen species (RNS) levels and increasing 1-(9Z-pentadecenoyl)-glycero-3-phospho-choline production. Keywords: neuroprotection, cholest-4-ene-3,6-dione, anti-ROS, lipidomics, molecular dockinghttps://www.dovepress.com/identification-of-cholest-4-ene-36-dione-as-a-novel-neuroprotectant-in-peer-reviewed-fulltext-article-DDDTneuroprotectioncholest-4-ene-36-dioneanti-roslipidomicsmolecular docking
spellingShingle Ren X
Lin F
Tang C
Liu Y
Liao G
Liang J
Luo W
Zhang L
Chen W
Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics
Drug Design, Development and Therapy
neuroprotection
cholest-4-ene-3
6-dione
anti-ros
lipidomics
molecular docking
title Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics
title_full Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics
title_fullStr Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics
title_full_unstemmed Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics
title_short Identification of cholest-4-ene-3,6-dione as a Novel Neuroprotectant in Ischemic Stroke and Its Lipidomics
title_sort identification of cholest 4 ene 3 6 dione as a novel neuroprotectant in ischemic stroke and its lipidomics
topic neuroprotection
cholest-4-ene-3
6-dione
anti-ros
lipidomics
molecular docking
url https://www.dovepress.com/identification-of-cholest-4-ene-36-dione-as-a-novel-neuroprotectant-in-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT renx identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT linf identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT tangc identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT liuy identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT liaog identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT liangj identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT luow identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT zhangl identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics
AT chenw identificationofcholest4ene36dioneasanovelneuroprotectantinischemicstrokeanditslipidomics